Zoledronic acid and secondary prevention of fractures

Editorial

Karim Anton Calis et al. N Engl J Med. 2007.

. 2007 Nov 1;357(18):1861-2.

doi: 10.1056/NEJMe078192. Epub 2007 Sep 17.

No abstract available

Comment in

Zoledronate, fractures, and mortality after hip fracture.
Karam R, Al-Khalidi H, Steinbuch M. Karam R, et al. N Engl J Med. 2008 Feb 28;358(9):969; author reply 968-9. N Engl J Med. 2008. PMID: 18314545 No abstract available.

Zoledronic acid and clinical fractures and mortality after hip fracture.
Lyles KW, Colón-Emeric CS, Magaziner JS, Adachi JD, Pieper CF, Mautalen C, Hyldstrup L, Recknor C, Nordsletten L, Moore KA, Lavecchia C, Zhang J, Mesenbrink P, Hodgson PK, Abrams K, Orloff JJ, Horowitz Z, Eriksen EF, Boonen S; HORIZON Recurrent Fracture Trial. Lyles KW, et al. N Engl J Med. 2007 Nov 1;357(18):1799-809. doi: 10.1056/NEJMoa074941. Epub 2007 Sep 17. N Engl J Med. 2007. PMID: 17878149 Free PMC article. Clinical Trial.